Clinical Trials Logo

Clinical Trial Summary

The objectives of this study were to: (1) evaluate the natural history of non-arteritic anterior ischemic optic neuropathy (NAION); (2) estimate the population incidence of NAION; and (3) identify potential risk factors for NAION.


Clinical Trial Description

The study population consisted of members of the Ingenix Normative Health Informatics (NHI) Database during 01/01/2003 through 12/31/2007, who were 18 years of age or older with at least 183 days of continuous enrollment in the database and without any doctor visits associated with a diagnosis of ischemic optic neuropathy during the 183 days prior to cohort entry. From the study population, patients with a claim associated with an ischemic optic neuropathy diagnosis code were identified as potential NAION cases (n = 3,732). From the potential NAION cases, definite and possible NAION cases were identified using medical record review and a claims algorithm (n=1,283). From the study population, patients without a claim associated with an ischemic optic neuropathy diagnosis code were randomly selected as controls (n = 20,000) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01260324
Study type Observational
Source Pfizer
Contact
Status Completed
Phase
Start date August 2008
Completion date March 2010

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02643615 - Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery N/A
Active, not recruiting NCT00000126 - Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup) N/A
Completed NCT00000127 - Ischemic Optic Neuropathy Decompression Trial (IONDT) Phase 3
Recruiting NCT03475173 - New Non-invasive Modalities for Assessing Retinal Structure and Function N/A
Completed NCT00450294 - Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair N/A
Withdrawn NCT01607671 - Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5% Phase 1
Recruiting NCT03851562 - Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy Phase 2
Recruiting NCT05353413 - Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy. N/A
Recruiting NCT02377271 - ENDOTHELION Study Group: Effect of Bosentan in NAION Patients Phase 3